AI model developed by SOPHiA GENETICS and UroCCR predicts post-operative outcomes in kidney cancer study

SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, and the French Kidney Cancer Research Network collaborated on a study using a multimodal algorithm to help predict post-operative outcomes for those facing renal cell carcinoma, with the results recently published in npj Precision Oncology.

Alzheimer’s Biomarkers Linked With Plasma Leptin Levels

Plasma leptin levels were linked with Alzheimer’s disease PET pathology in cognitively unimpaired older adults in Korea. Lower baseline leptin was associated with a greater

May 4, 2024

Why climate change means more blood shortages: Q&A with HHS’ Rachel Levine

This summer, the American Red Cross declared an emergency blood shortage in the U.S. There’s a seasonal pattern to blood donations, which often dip over

September 24, 2024

Calliditas wins full approval for steroid drug in rare autoimmune disease

Calliditas Therapeutics converted its accelerated approval for Tarpeyo in primary immunoglobulin A nephropathy (IgAN) to a full approval, marking what it says is an important

December 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.